These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38143011)

  • 1. DHX33 mediates p53 to regulate mevalonate pathway gene transcription in human cancers.
    Nie G; Chen S; Song Q; Zou D; Li M; Tang X; Deng Y; Huang B; Yang M; Lv G; Zhang Y
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130547. PubMed ID: 38143011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo.
    Wang X; Feng W; Peng C; Chen S; Ji H; Zhong H; Ge W; Zhang Y
    Cancer Sci; 2020 Oct; 111(10):3564-3575. PubMed ID: 32767810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate.
    Zhang Y; Saporita AJ; Weber JD
    Mol Cell Biol; 2013 Apr; 33(8):1594-607. PubMed ID: 23401854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA helicase DHX33 regulates HMGB family genes in human cancer cells.
    Wang X; Chen S; Wen F; Zeng Y; Zhang Y
    Cell Signal; 2023 Oct; 110():110832. PubMed ID: 37543097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DHX33 as a mediator of rRNA synthesis and cell growth.
    Zhang Y; Forys JT; Miceli AP; Gwinn AS; Weber JD
    Mol Cell Biol; 2011 Dec; 31(23):4676-91. PubMed ID: 21930779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of DHX33 in c-Myc-induced cancers.
    Fu J; Liu Y; Wang X; Yuan B; Zhang Y
    Carcinogenesis; 2017 Jun; 38(6):649-660. PubMed ID: 28498893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHX33 Interacts with AP-2β To Regulate
    Wang J; Feng W; Yuan Z; Weber JD; Zhang Y
    Mol Cell Biol; 2019 Sep; 39(17):. PubMed ID: 31182639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHX33 Transcriptionally Controls Genes Involved in the Cell Cycle.
    Yuan B; Wang X; Fan C; You J; Liu Y; Weber JD; Zhong H; Zhang Y
    Mol Cell Biol; 2016 Dec; 36(23):2903-2917. PubMed ID: 27601587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant DHX33 Protein Possesses Dual DNA/RNA Helicase Activity.
    Wang X; Ge W; Zhang Y
    Biochemistry; 2019 Jan; 58(4):250-258. PubMed ID: 29870660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHX33 promotes colon cancer development downstream of Wnt signaling.
    Zhu Y; Du Y; Zhang Y
    Gene; 2020 Apr; 735():144402. PubMed ID: 32004669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
    Liu Z; Ouyang G; Lu W; Zhang H
    Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
    Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
    Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
    Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
    J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
    Moon SH; Huang CH; Houlihan SL; Regunath K; Freed-Pastor WA; Morris JP; Tschaharganeh DF; Kastenhuber ER; Barsotti AM; Culp-Hill R; Xue W; Ho YJ; Baslan T; Li X; Mayle A; de Stanchina E; Zender L; Tong DR; D'Alessandro A; Lowe SW; Prives C
    Cell; 2019 Jan; 176(3):564-580.e19. PubMed ID: 30580964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mutant p53 through the mevalonate pathway.
    Freed-Pastor W; Prives C
    Nat Cell Biol; 2016 Oct; 18(11):1122-1124. PubMed ID: 27784901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of DHX33 in promoting Warburg effect via regulation of glycolytic genes.
    Peng C; Hou ST; Deng CX; Zhang Y
    J Cell Physiol; 2021 Feb; 236(2):981-996. PubMed ID: 32617965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition.
    Wang H; Yu J; Wang X; Zhang Y
    Cell Signal; 2019 Feb; 54():170-178. PubMed ID: 30552990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of immune implication and prognostic value of DHX33 in sarcoma.
    Zhang X; Shao Y; Zhou Y; Zhu Z; Wang X
    Medicine (Baltimore); 2023 Apr; 102(17):e33654. PubMed ID: 37115050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between mutant p53 and the mevalonate pathway.
    Parrales A; Thoenen E; Iwakuma T
    Cell Death Differ; 2018 Mar; 25(3):460-470. PubMed ID: 29238070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of the prognostic and immunological role of DHX33 in pan-cancer.
    Ding J; Zhou J; Shen X; Zhang M; Feng X; Xu Z
    Environ Toxicol; 2023 Aug; 38(8):2011-2021. PubMed ID: 37256545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.